Kazuko Matsuda

1.2k total citations
38 papers, 644 citations indexed

About

Kazuko Matsuda is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Kazuko Matsuda has authored 38 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Kazuko Matsuda's work include Asthma and respiratory diseases (9 papers), Macrophage Migration Inhibitory Factor (7 papers) and Pharmacological Effects and Assays (6 papers). Kazuko Matsuda is often cited by papers focused on Asthma and respiratory diseases (9 papers), Macrophage Migration Inhibitory Factor (7 papers) and Pharmacological Effects and Assays (6 papers). Kazuko Matsuda collaborates with scholars based in United States, Japan and Australia. Kazuko Matsuda's co-authors include Naoki Matsuda, Naoko Morita, Masami Watanabe, Kirk W. Johnson, Yuichi Iwaki, Hiroyuki Tsutsumi, Shunzo Chiba, Pearay L. Ogra, Stacey L. House and Lawrence M. Lewis and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Neurology.

In The Last Decade

Kazuko Matsuda

37 papers receiving 624 citations

Peers

Kazuko Matsuda
Bobby Y. Reddy United States
Asako Itakura United States
Yingchi Zhang China
Jiaqing Pang United States
Chung-Ping Liao United States
Hindi Al‐Hindi Saudi Arabia
Juan Lorente Spain
Virginie Millet France
Aubryanna Hettinghouse United States
Agata Szade Poland
Bobby Y. Reddy United States
Kazuko Matsuda
Citations per year, relative to Kazuko Matsuda Kazuko Matsuda (= 1×) peers Bobby Y. Reddy

Countries citing papers authored by Kazuko Matsuda

Since Specialization
Citations

This map shows the geographic impact of Kazuko Matsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Matsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Matsuda more than expected).

Fields of papers citing papers by Kazuko Matsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuko Matsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Matsuda. The network helps show where Kazuko Matsuda may publish in the future.

Co-authorship network of co-authors of Kazuko Matsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Matsuda. A scholar is included among the top collaborators of Kazuko Matsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Matsuda. Kazuko Matsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qi, Hongyan, et al.. (2025). Enhancement of ABCA1 and ABCG1 Expression and Cholesterol Efflux by a Metabolite of Tipelukast: A Potential Therapeutic Strategy for Atherosclerosis. Journal of Atherosclerosis and Thrombosis. 33(1). 55–77. 1 indexed citations
2.
Oskarsson, Björn, Nicholas J. Maragakis, Richard Bedlack, et al.. (2021). MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis in a Phase IIb/III Study: COMBAT-ALS Study Design. Neurodegenerative Disease Management. 11(6). 431–443. 29 indexed citations
3.
Alban, Tyler, Defne Bayık, Balint Otvos, et al.. (2020). Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression. Frontiers in Immunology. 11. 1191–1191. 105 indexed citations
4.
Oskarsson, Björn, et al.. (2020). COMBAT-ALS Phase 2b/3 Trial of MN-166 (Ibudilast) in ALS: Study Design and Trial Update (5149). Neurology. 94(15_supplement). 2 indexed citations
5.
Fox, Robert J., Matthew Karafa, Christian Barro, et al.. (2019). Effect of Ibudilast on Neurofilament-light Chain in Progressive MS: Analysis from a Phase II Trial (P3.2-033). Neurology. 92(15_supplement). 4 indexed citations
6.
Fox, Robert J., Christopher S. Coffey, Merit Cudkowicz, et al.. (2015). NN 102/SPRINT-MS Phase II Trial of Ibudilast in Progressive MS: Baseline Characteristics (P7.214). Neurology. 84(14_supplement). 1 indexed citations
7.
House, Stacey L., Kazuko Matsuda, Geoffrey O'Brien, et al.. (2015). Efficacy of a new intravenous β2-adrenergic agonist (bedoradrine, MN-221) for patients with an acute exacerbation of asthma. Respiratory Medicine. 109(10). 1268–1273. 4 indexed citations
8.
Lewis, Lawrence M., Ian Ferguson, Stacey L. House, et al.. (2013). Albuterol Administration Is Commonly Associated With Increases in Serum Lactate in Patients With Asthma Treated for Acute Exacerbation of Asthma. CHEST Journal. 145(1). 53–59. 31 indexed citations
9.
Matsuda, Kazuko, Malath Makhay, Kirk W. Johnson, & Yuichi Iwaki. (2012). Evaluation of Bedoradrine Sulfate (MN-221), a Novel, Highly Selective Beta2-Adrenergic Receptor Agonist for the Treatment of Asthma via Intravenous Infusion. Journal of Asthma. 49(10). 1071–1078. 7 indexed citations
10.
Aubuchon, Kristen, Kazuko Matsuda, Stacey L. House, John A. Schneider, & Lawrence M. Lewis. (2012). Increased serum albuterol concentrations may be associated with elevations of serum lactate in subjects with acute asthma exacerbations. Digital Commons@Becker (Washington University School of Medicine). 2 indexed citations
11.
Ricart, Alejandro D., Edward Ashton, Matthew M. Cooney, et al.. (2011). A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 68(4). 959–970. 27 indexed citations
12.
13.
14.
Johnson, Kirk W., et al.. (2010). Cardiovascular Effects of MN-221 (Bedoradrine) Administered With Albuterol in Dogs. CHEST Journal. 138(4). 174A–174A. 4 indexed citations
15.
16.
17.
Matsuda, Yasuhiro, et al.. (2010). Development of a real-time quantitative PCR assay for detection of a stable genomic region of BK virus. Virology Journal. 7(1). 295–295. 13 indexed citations
18.
Matsuda, Naoki, Naoko Morita, Kazuko Matsuda, & Masami Watanabe. (1998). Proliferation and Differentiation of Human Osteoblastic Cells Associated with Differential Activation of MAP Kinases in Response to Epidermal Growth Factor, Hypoxia, and Mechanical Stressin Vitro. Biochemical and Biophysical Research Communications. 249(2). 350–354. 170 indexed citations
19.
Matsuda, Kazuko, Hiroyuki Tsutsumi, Yuko Yoto, et al.. (1996). Characteristics of IL-6 and TNF-α production by respiratory syncytial virus-infected macrophages in the neonate. Journal of Medical Virology. 48(2). 199–203. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bobby Y. Reddy Breakdown of academic impact, for papers by Asako Itakura Breakdown of academic impact, for papers by Yingchi Zhang Breakdown of academic impact, for papers by Jiaqing Pang Breakdown of academic impact, for papers by Chung-Ping Liao Breakdown of academic impact, for papers by Hindi Al‐Hindi Breakdown of academic impact, for papers by Juan Lorente Breakdown of academic impact, for papers by Virginie Millet Breakdown of academic impact, for papers by Aubryanna Hettinghouse Breakdown of academic impact, for papers by Agata Szade
Rankless by CCL
2026